Portal designs often amplify alarm rather than offering context ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

Approximately a quarter of individuals with primary sclerosing cholangitis experience moderate-severe pruritus.

GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company’s marketing strategyPartnership ...

Hemophilia B gene therapy reduced bleeding and supported lasting clotting levels, even in some patients with antibodies, new ...

Detailed price information for Tg Therapeutics (TGTX-Q) from The Globe and Mail including charting and trades.

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced preliminary, unaudited fourth quarter and full ...

Learn how to understand dog blood work with this comprehensive guide. Decode CBC, chemistry panels, liver, and kidney values.